Status:
RECRUITING
Accuracy of the Polymerase Chain Reaction of Ulnar Perineural Subcutaneous Aspirate Guided by Ultrasound for the Diagnosis and Monitoring of Leprosy Cure
Lead Sponsor:
University of Brasilia
Conditions:
Leprosy
Leprosy Neuropathy
Eligibility:
All Genders
14+ years
Phase:
NA
Brief Summary
\*\*Brief Summary\*\* Leprosy is a chronic granulomatous infectious disease caused by \*Mycobacterium leprae\* or \*Mycobacterium lepromatosis\*, characterized by peripheral nerve involvement that ma...
Detailed Description
Leprosy is a chronic infectious disease caused by Mycobacterium leprae and is characterized by skin and peripheral nerve involvement. Neural impairment is the main determinant of disability and long-t...
Eligibility Criteria
Inclusion Criteria:
Individuals aged 14 years or older;
Clinical suspicion of leprosy based on dermatologic or neurologic examination OR;
Presence of peripheral nerve enlargement or skin lesions compatible with leprosy;
Ability to provide written informed consent.
-
Exclusion Criteria:
Previous treatment for leprosy;
Contraindication to the aspiration procedure (e.g., coagulopathy or anticoagulant therapy);
Local infection at the puncture site;
Inability or unwillingness to provide informed consent.
Key Trial Info
Start Date :
January 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2027
Estimated Enrollment :
108 Patients enrolled
Trial Details
Trial ID
NCT07515989
Start Date
January 1 2026
End Date
August 31 2027
Last Update
April 7 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Brasília
Brasília, Federal District, Brazil, 70.830-200